AKT1 and non-small cell lung carcinoma: Furthermore, resveratrol has been shown to suppress HK-II expression and glycolysis in non-small cell lung cancer (NSCLC), with the Akt signaling pathway proposed as a key molecular mechanism underlying its anti-tumor effects [91,92].